KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Other financing activities (2016 - 2025)

Historic Other financing activities for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $39.0 million.

  • Tenet Healthcare's Other financing activities fell 3606.56% to $39.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $55.0 million, marking a year-over-year decrease of 517.24%. This contributed to the annual value of $55.0 million for FY2025, which is 517.24% down from last year.
  • Latest data reveals that Tenet Healthcare reported Other financing activities of $39.0 million as of Q4 2025, which was down 3606.56% from $71.0 million recorded in Q3 2025.
  • Tenet Healthcare's Other financing activities' 5-year high stood at $71.0 million during Q3 2025, with a 5-year trough of -$102.0 million in Q1 2022.
  • Moreover, its 5-year median value for Other financing activities was $2.0 million (2022), whereas its average is $4.3 million.
  • In the last 5 years, Tenet Healthcare's Other financing activities skyrocketed by 330000.0% in 2024 and then crashed by 70000.0% in 2025.
  • Over the past 5 years, Tenet Healthcare's Other financing activities (Quarter) stood at -$11.0 million in 2021, then soared by 127.27% to $3.0 million in 2022, then skyrocketed by 2133.33% to $67.0 million in 2023, then decreased by 8.96% to $61.0 million in 2024, then crashed by 36.07% to $39.0 million in 2025.
  • Its Other financing activities was $39.0 million in Q4 2025, compared to $71.0 million in Q3 2025 and -$16.0 million in Q2 2025.